English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Disclaimer: Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter. Beckman Coulter did not provide funding for these studies.
Clinical Studies
Aiming to Close the Knowledge Gap
Learn about new key clinical studies for important disease states and diagnostic innovations.
Immunoassay
Coefficients of variation (CV) of less than 1% for all samples were achieved by incorporating new pipetting profiles
Immunoassay
A study comparing results of 3 assays showed improved sensitivity & precision on the DxI 9000 analyzer
Hematology
High MDW results in patients with occult symptoms ⬇ time to antibiotics by ~1 h
Trends
Sharing best practices from around the world
Learn how clinicians around the world are tackling important disease states
Automation
DxA 5000 Reduces TAT in Multiple Sample Types Receiving by a Typical Blood Sciences Lab
Past Clinical Studies
- >95% Achieved criteria for analytical agreement based on “Allowable Total Difference Zone” following Assay Migration Guidance
- Study shows including Scopio’s FF-PBS application saves 12.76 work hours/month
- Study Shows Differences in the 3 FLC Assays Can = Clinically Different Results
- Study of 1,049 patients excludes AMI 3 hours after ED presentation with hsTnI
- Study establishes age-and sex-specific pediatric reference intervals for 47 hematologic parameters
- Study validates semi-quantitative diagnostic method with 90% sensitivity
- 1,020 COVID-19-positive patients: higher hs-cTnI levels = higher rates of mechanical ventilation
- Multi-center study finds 87.59% auto verification pass accurate rate
- Study shows abnormal MDW increased probability of sepsis
- Estimating asymptomatic COVID-19 & potential community transmission
- Study shows 100% sensitivity for two accelerated diagnostic pathways
- Preventing and responding COVID-19 on college campuses
- Sars-cov-2 testing and school reopening
- Implementation pooled surveillance testing program asymptomatic sars-cov-2
- Results of universal testing of 1970 nursing home residents
- Study of 3.2-million people shows seropositivity = decreased risk of infection
Past Trends
- Abnormal MDW 27.3 Changed Patient’s Trajectory
- MDW Biomarker Identified Risk of Severe Infection
- Microscopic Reviews Reduced by 63% Using Automated Urinalysis
- Clinical reference lab turns to mass antigen testing in-house for faster results
- Maximizing serology testing to combat COVID-19 surge
- IL-6 testing as a standard for COVID-19 patients
- U.K. hospital reduces patient wait times following introduction of Access hsTnI
Disclaimer: Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter. Beckman Coulter did not provide funding for these studies.
